Myriad Genetics, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionCwm, Llc
Latest Disclosed Ownership71,153 shares
Latest Disclosed Value $ 320,189
Cwm, Llc reports 0.87% decrease in ownership of MYGN / Myriad Genetics, Inc.

On May 14, 2026 - Cwm, Llc filed a 13F-HR form disclosing ownership of 71,153 shares of Myriad Genetics, Inc. (US:MYGN) valued at $320,188 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 71,774 shares of Myriad Genetics, Inc.. The current value of the position is $313,073 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F MYRIAD GENETICS COM 62855J104 71,153 -621 -0.87 320 0.0008
2026-01-26 2025-12-31 13F MYRIAD GENETICS COM 62855J104 71,774 8,449 13.34 0 0.0012
2025-10-15 2025-09-30 13F MYRIAD GENETICS COM 62855J104 63,325 38,998 160.31 0 0.0014
2025-07-25 2025-06-30 13F MYRIAD GENETICS COM 62855J104 24,327 14,531 148.34 0 0.0005
2025-05-01 2025-03-31 13F MYRIAD GENETICS COM 62855J104 9,796 8,397 600.21 0 0.0003
2025-02-04 2024-12-31 13F MYRIAD GENETICS COM 62855J104 1,399 -90 -6.04 0 0.0001
2024-10-08 2024-09-30 13F MYRIAD GENETICS COM 62855J104 1,489 68 4.79 0 0.0002
2024-07-10 2024-06-30 13F MYRIAD GENETICS COM 62855J104 1,421 30 2.16 0 0.0002
2024-04-05 2024-03-31 13F MYRIAD GENETICS COM 62855J104 1,391 8 0.58 0 0.0001
2024-02-01 2023-12-31 13F MYRIAD GENETICS COM 62855J104 1,383 -1,273 -47.93 0 0.0001
2023-10-11 2023-09-30 13F MYRIAD GENETICS COM 62855J104 2,656 -347 -11.56 0 0.0003
2023-08-03 2023-06-30 13F MYRIAD GENETICS COM 62855J104 3,003 -1,195 -28.47 0 0.0004
2023-05-01 2023-03-31 13F MYRIAD GENETICS COM 62855J104 4,198 -2 -0.05 0 0.0007
2023-02-01 2022-12-31 13F MYRIAD GENETICS COM 62855J104 4,200 -91 -2.12 0 -100.00 0.0004
2022-10-27 2022-09-30 13F MYRIAD GENETICS COM 62855J104 4,291 648 17.79 82 24.24 0.0007
2022-07-28 2022-06-30 13F MYRIAD GENETICS COM 62855J104 3,643 159 4.56 66 -25.00 0.0005
2022-04-21 2022-03-31 13F MYRIAD GENETICS COM 62855J104 3,484 -92 -2.57 88 -11.11 0.0006
2022-01-31 2021-12-31 13F MYRIAD GENETICS COM 62855J104 3,576 201 5.96 99 -3.88 0.0007
2021-09-15 2021-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2021-07-29 2021-06-30 13F MYRIAD GENETICS COM 62855J104 3,375 0 103 0.0008
2021-09-15 2021-03-31 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2021-04-27 2021-03-31 13F MYRIAD GENETICS COM 62855J104 266,390 263,015 8,112 0.0713
2021-09-15 2020-12-31 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2021-01-27 2020-12-31 13F MYRIAD GENETICS COM 62855J104 293,068 289,693 5,795 0.0543
2021-09-15 2020-09-30 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2020-10-19 2020-09-30 13F MYRIAD GENETICS COM 62855J104 293,068 289,693 3,822 0.0425
2021-09-15 2020-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2020-07-22 2020-06-30 13F MYRIAD GENETICS COM 62855J104 293,717 290,342 3,331 0.0395
2021-09-15 2020-03-31 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2020-04-28 2020-03-31 13F MYRIAD GENETICS COM 62855J104 741,836 738,461 10,616 0.1581
2021-09-14 2019-12-31 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2020-01-27 2019-12-31 13F MYRIAD GENETICS COM 62855J104 610,279 606,904 16,618 0.2123
2021-09-14 2019-09-30 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2019-10-22 2019-09-30 13F MYRIAD GENETICS COM 62855J104 597,335 593,960 17,102 0.2490
2021-09-14 2019-06-30 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 0 0.00 103 0.00 0.0008
2019-07-31 2019-06-30 13F MYRIAD GENETICS COM 62855J104 464,899 461,524 12,915 0.2136
2021-09-02 2019-03-31 13F/A-1 MYRIAD GENETICS COM 62855J104 3,375 -378,802 -99.12 103 -99.07 0.0008
2019-04-22 2019-03-31 13F MYRIAD GENETICS COM 62855J104 415,692 33,515 13,801 0.2768
2019-01-25 2018-12-31 13F MYRIAD GENETICS COM 62855J104 382,177 67,211 21.34 11,110 -23.32 0.2774
2018-10-29 2018-09-30 13F MYRIAD GENETICS COM 62855J104 314,966 32,677 11.58 14,488 37.34 0.3699
2018-07-31 2018-06-30 13F MYRIAD GENETICS COM 62855J104 282,289 1,650 0.59 10,549 27.20 0.3471
2018-04-26 2018-03-31 13F MYRIAD GENETICS COM 62855J104 280,639 -21,454 -7.10 8,293 -20.07 0.3295
2018-01-16 2017-12-31 13F MYRIAD GENETICS COM 62855J104 302,093 -74,767 -19.84 10,375 -23.91 0.4607
2017-10-16 2017-09-30 13F MYRIAD GENETICS COM 62855J104 376,860 -161,299 -29.97 13,635 -1.95 0.6446
2017-07-17 2017-06-30 13F MYRIAD GENETICS COM 62855J104 538,159 357 0.07 13,906 34.67 0.7126
2017-04-17 2017-03-31 13F MYRIAD GENETICS COM 62855J104 537,802 43,031 8.70 10,326 25.19 0.5838
2017-01-19 2016-12-31 13F MYRIAD GENETICS COM 62855J104 494,771 49,510 11.12 8,248 -9.99 0.5055
2016-10-17 2016-09-30 13F MYRIAD GENETICS COM 62855J104 445,261 222,706 100.07 9,163 34.55 0.6325
2016-07-21 2016-06-30 13F MYRIAD GENETICS COM 62855J104 222,555 15,906 7.70 6,810 -11.96 0.4967
2016-04-18 2016-03-31 13F MYRIAD GENETICS COM 62855J104 206,649 -1,678 -0.81 7,735 -13.97 0.6792
2016-02-01 2015-12-31 13F MYRIAD GENETICS COM 62855J104 208,327 7,547 3.76 8,991 19.48 0.8785
2015-10-30 2015-09-30 13F MYRIAD GENETICS COM 62855J104 200,780 23,931 13.53 7,525 25.19 0.7575
2015-07-09 2015-06-30 13F MYRIAD GENETICS COM 62855J104 176,849 35,588 25.19 6,011 20.20 0.5767
2015-04-30 2015-03-31 13F MYRIAD GENETICS COM 62855J104 141,261 28,991 25.82 5,001 30.78 0.5064
2015-02-12 2014-12-31 13F MYRIAD GENETICS COM 62855J104 112,270 18,332 19.51 3,824 5.55 0.4641
2014-11-14 2014-09-30 13F MYRIAD GENETICS COM 62855J104 93,938 16,492 21.29 3,623 20.21 0.5261
2014-08-14 2014-06-30 13F MYRIAD GENETICS COM 62855J104 77,446 21,322 37.99 3,014 57.06 0.5393
2014-05-16 2014-03-31 13F MYRIAD GENETICS COM 62855J104 56,124 29,586 111.49 1,919 242.07 0.2616
2014-02-14 2013-12-31 13F MYRIAD GENETICS COM 62855J104 26,538 9,420 55.03 561 39.55 0.0875
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 17,118 17,118 402 0.1055
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.